Emcure Pharmaceuticals IPO
ListedEmcure Pharmaceuticals IPO Details
-
Bidding Date
03-Jul-2024 to
05-Jul-2024 -
Issue Size
₹1952.03 Cr
-
Price Band
₹960 to ₹1008
-
Allotment date
08-Jul-2024
-
Listing date
10-Jul-2024
-
Lot size
14
-
No. of shares
1,93,65,347
-
Fresh issue/OFS
₹800 Cr/₹1152.03 Cr
About Emcure Pharmaceuticals Company
Emcure Pharmaceuticals Ltd is an Indian pharmaceutical company, renowned for developing, manufacturing, and globally marketing a wide range of pharmaceutical products. Established in 1981, the company has built a reputation as a research and development (R&D) driven entity. Their business model is centered around a differentiated product portfolio that includes orals, injectables, and biotherapeutics, enabling them to cater to a broad range of therapeutic areas. Their operations span over 70 countries, with significant market presence in India, Europe, and Canada. Their operations are segmented into chronic and acute therapeutic areas, with a significant emphasis on the former due to its higher growth potential. Chronic therapeutic areas, including sub-chronic, accounted for 46.22% of their total Domestic Sales for FY24.
Read our in-depth analysis of the Emcure Pharmaceuticals Ltd IPO Here
Subscription Status
-
Category
Status
-
QIBs
195.8x
-
NIIs
48.3x
-
Retail
7.2x
-
Others
--
-
Total
67.8x
FAQs for Emcure Pharmaceuticals IPO.
What is the issue size of Emcure Pharmaceuticals IPO?
The issue size of Emcure Pharmaceuticals is ₹1,952.03 Cr.
What is the industry of Emcure Pharmaceuticals?
Emcure Pharmaceuticals falls into Pharmaceuticals industry.
Where Emcure Pharmaceuticals IPO will be listed?
The Emcure Pharmaceuticals IPO will be listed on both NSE and BSE.
What are the open and close dates for the Emcure Pharmaceuticals IPO?
The open and close dates for the Emcure Pharmaceuticals are 03-Jul-2024 & 05-Jul-2024.
What are the price band for Emcure Pharmaceuticals IPO?
The price band for the Emcure Pharmaceuticals ipo is ₹960 to ₹1008
What is the listing date of Emcure Pharmaceuticals IPO?
The listing date of Emcure Pharmaceuticals IPO is 10-Jul-2024.
What is the purpose for the Emcure Pharmaceuticals IPO?
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
How much times Emcure Pharmaceuticals IPO subscribed?
Emcure Pharmaceuticals total subscription ratio is 67.8X.
What are the key financials for the Emcure Pharmaceuticals IPO?
Key financial of the Emcure Pharmaceuticals are:
| Emcure Pharmaceuticals | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 6658.25 | 5985.81 | 5855.39 |
| EBIT (₹ Cr) | 917.32 | 921.06 | 1085.05 |
| Proft after Tax (₹ Cr) | 527.58 | 561.85 | 702.56 |
| Debt (₹ Cr) | 2072.49 | 2181.61 | 2077.27 |
| Net Worth (₹ Cr) | 3121.77 | 2649.66 | 2114.14 |
| RoE (%) | 16.9 | 21.2 | 33.23 |